A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years

• Status: Completed
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to determine whether iodide supplementation of neonates born under 31 weeks gestation improves neurodevelopment measured at two years of age.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Oxford
• Collaborators: National Institute for Health Research, United Kingdom; University of Dundee
• Treatments: Iodine

Criteria

Inclusion Criteria:

• All infants born under 31 weeks gestation

Exclusion Criteria:

• Mother exposed to excess iodine during pregnancy or delivery